Patent · US Active

Synthetic linear apelin mimetics for the treatment of heart failure

US8921307B2 · kind B2 · utility

4Cited by

8References

24Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Frederic Zecri · Cambridge, US
Kayo Yasoshima · Cambridge, US
Philipp Grosche · Inzlingen, DE
Jun Yuan · Guilford, US
Hongjuan Zhao · Lexington, US

Key dates

Filing date	Nov 18, 2013
Grant date	Dec 30, 2014
Priority date	—
Expiry date	Nov 18, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a synthetic polypeptide of Formula I′ (SEQ ID NO: 1):X1-X2-X3-R—X5-X6-X7-X8-X9-X10-X11-X12-X13 I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.